Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
1mg/5ml Oral Solution 473ml
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Cuvposa is a prescription medication used to reduce chronic severe drooling in children aged 3 to 16 years with certain neurologic conditions, such as cerebral palsy. Excessive drooling can lead to social discomfort and skin irritation, among other complications.
Glycopyrrolate, the active ingredient in Cuvposa, is an anticholinergic agent. It works by blocking acetylcholine receptors, which reduces saliva production, helping to manage and decrease drooling.
Fact Table |
|
Formula |
C19H28BrNO3 |
License |
US FDA |
Bioavailability |
3% (oral) |
Legal status |
Prescription only |
Chemical Name |
(RS)-3-[2-Cyclopentyl-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidinium bromide |
Elimination half-life |
0.83-1.25 hours |
Dosage (Strength) |
1 mg/5 mL oral solution |
Pregnancy |
Consult a doctor |
Brands |
Cuvposa, Robinul, Seebri Neohaler |
Protein binding |
Not significantly protein bound |
PubChem CID |
3496 |
MedlinePlus |
a682620 |
ChEBI |
CHEBI:5550 |
ATC code |
A03AB02, R03BB06 |
DrugBank |
DB00986 |
KEGG |
D00533 |
Routes of administration |
Oral, Inhalation, Intravenous |
Cuvposa is typically taken three times daily, 1 hour before or 2 hours after meals.
The dosage is based on the child's weight and response to treatment.
Shake the bottle well before each use.
The active ingredient in Cuvposa is glycopyrrolate.
Common drug-drug interactions with this drug can include:
Do not use Cuvposa if your child is allergic to glycopyrrolate or any other ingredients in the solution.
Inform your doctor if your child has a history of urinary retention, glaucoma, gastrointestinal disorders, or heart disease before starting this medication.
Common side effects may include:
Cuvposa [package insert]. Raleigh, NC: Merz; 2016.